A. MERCHANT ET AL.: "An efficient route to human bispecific IgG." NATURE BIOTECHNOLOGY, vol. 16, July 1998 (1998-07), pages 677-681, XP002141015 New York, USA cited in the application (B1)

J. RIDGWAY ET AL.: "'Knobs-into-holes' engineering of antibody CH3 domains for heavy chain heterodimerization." PROTEIN ENGINEERING, vol. 9, no. 7, 1996, pages 617-621, XP002084766 U.K. cited in the application (B1)

L. CHAN ET AL.: "Variable region domain exchange in human IgGs promotes antibody complex formation with accompanying structural changes and altered effector functions." MOLECULAR IMMUNOLOGY, vol. 41, no. 5, July 2004 (2004-07), pages 527-538, XP002519713 U.K. (B1)

S. MORRISON: "Two heads are better than one." NATURE BIOTECHNOLOGY, vol. 25, no. 11, November 2007 (2007-11), pages 1233-1234, XP002470803 New York, USA cited in the application (B1)

Z. XIE ET AL.: "A new format of bispecific antibody: highly efficient heterodimerization, expression and tumor cell lysis." JOURNAL OF IMMUNOLOGICAL METHODS, vol. 296, 2005, pages 95-101, XP004738464 Amsterdam, The Netherlands (B1)

WO-A-93/06217 (B1)

WO-A-96/27011 (B1)

WO-A-99/37791 (B1)

T. SIMON & K. RAJEWSKY: "Antibody domain mutants demonstrate autonomy of the antigen binding site." THE EMBO JOURNAL, vol. 9, no. 4, April 1990 (1990-04), pages 1051-1056, XP002492563 UK (B1)